索特拉健康公司
SHC
17.89
-0.18
-1.00%
索特拉健康公司
US · SHC
#2097 按市值排名
上市于 2020
17.89
-0.18
-1.00%
实时 - 追踪5344个代码 - 心跳于530秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 103.11% -0.03pp
- 机构数量
- 361 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Hedge Fund54.40%
Mutual Fund43.96%
Individual/Insider2.21%
Public Company1.95%
Sovereign Wealth Fund1.25%
Government Pension Fund0.68%
Private Company0.59%
Insurance Company0.11%
主要股东 截至 2026-06-30
Sessa Capital IM, L.P.
9.48% · 27.05M 股
Darsana Capital Partners LP
9.46% · 27.00M 股
BlackRock
8.46% · 24.15M 股
Sculptor Capital Management, Inc.
8.41% · 24.00M 股
Sachem Head Capital Management LP
5.45% · 15.56M 股
Vanguard Capital Management, LLC
4.86% · 13.86M 股
Vanguard Portfolio Management, LLC
4.19% · 11.95M 股
T. Rowe Price Group, Inc.
3.78% · 10.78M 股
AQR Capital Management
3.75% · 10.69M 股
Janus Henderson Group plc
2.94% · 8.40M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 23次买入 · 23次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Michael Petras | Chairperson & CEO | 1.53% |
| Alton Shader | Chief Executive Officer | 0.20% |
| Alexander Dimitrief | Senior Vice President | 0.10% |
| Michael Rutz | President of Sterigenics | 0.09% |
| Ann Klee | Independent Director | 0.04% |
| Jonathan Lyons | Senior Vice President | 0.04% |
| Sean Cunningham | Independent Director | 0.03% |
| James Neary | Independent Director | 0.03% |
| Vincent Petrella | Independent Director | 0.03% |
| Ruoxi Chen | Independent Director | 0.03% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-16 | Michael Petras | Chairperson & CEO | Open Market Disposition | -1,144,515 | $18.50 |
| 2026-08-06 | Michael Rutz | President of Sterigenics | Open Market Disposition | -150,000 | $18.84 |
| 2026-08-04 | Jonathan Lyons | Senior Vice President | Sale to Issuer | -11,316 | $17.98 |
| 2026-05-25 | Alton Shader | Chief Executive Officer | Other Acquisition | +579,573 | -- |
| 2026-05-25 | Alton Shader | Chief Executive Officer | Other Derivative Acquisition | +101,817 | -- |
| 2026-05-21 | James Neary | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Sean Cunningham | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Vincent Petrella | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Christopher Simon | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Ann Klee | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Ruoxi Chen | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | David Wheadon | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Richard Kyle | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Karen Flynn | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Kenneth Krause | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-12 | Warburg Pincus LLC | -- | Private Disposition | -19,102,952 | $15.17 |
| 2026-05-12 | GTCR LLC | -- | Private Disposition | -12,654,291 | $15.17 |
| 2026-03-31 | Erika Ostrowski | Vice President, Deputy General Counsel & Corporate Secretary | Initial Statement of Beneficial | 0 | -- |
| 2026-03-30 | Alexander Dimitrief | Senior Vice President | Sale to Issuer | -7,941 | $14.34 |
| 2026-03-01 | Alexander Dimitrief | Senior Vice President | Sale to Issuer | -14,744 | $15.91 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
索特拉健康公司 讨论区 0 条评论